HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer].

Abstract
Data on the treatment of advanced penile carcinoma especially for chemotherapy are very limited. Due to the results of recent studies there has been a shift to taxan/cisplatinum based regimens. Initial case reports also showed a response to targeted therapy especially antibodies against epidermal growth factor receptor (EGFR). Nevertheless, a curative treatment by medicinal approaches alone does not appear to be possible for metastatic penile cancer and can be only cured by multimodal approaches, including neoadjuvant and adjuvant chemotherapy and salvage lymph node dissection. Palliative chemotherapy of advanced penile cancer has to be individually adapted and weighed against best supportive care for the final decision.
AuthorsC Protzel, A K Seitz, O W Hakenberg, M Retz
JournalDer Urologe. Ausg. A (Urologe A) Vol. 52 Issue 11 Pg. 1556-60, 1562-3 (Nov 2013) ISSN: 1433-0563 [Electronic] Germany
Vernacular TitleNeoadjuvante, adjuvante und palliative Chemotherapie des Peniskarzinoms.
PMID24126503 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
Topics
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Chemotherapy, Adjuvant (methods)
  • Humans
  • Male
  • Molecular Targeted Therapy (methods)
  • Neoadjuvant Therapy (methods)
  • Palliative Care (methods)
  • Penile Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: